Hibiscus: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antispholipid syndrome

Belizna Cristina1,2, Abad Sebastien3, Alijotas-Reig Jaume4,5, Amital Howard6, Amoura Zahir7, Andreoli Laura8, Andres Emmanuel9, Aouba Achile10, Apras Bilgen Sule11, Arnaud Laurent12, BienvenuBoris13, Bitsadze Viktoriya14, Blanco Patrick15,16, Blank Miri6, Borghi Maria Orietta17, CaligaroAntonia18, Candrea Elisabeta19, Canti Valentina20, Chiche Laurent21, Chretien Jean Marie22, Cohen Tervaert Jan Willem23,24, Damian Laura25, Delross Teresa18, Dernis Emmanuelle26, Devreese Katrien27, Djokovic Aleksandra28, Esteve Esteverde Enrique29, Favaro Maria18, Fassot Céline2, Ferer Raquel29, Godon Alban30, Hamidou Mohamed31,  Henrion Daniel2, Imbert Bernard32, Jacobsen Eva Marie33, Jeandel Pierre Yves34, Jeannin Pascale30,

Read More

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study Amelia Ruffatti1 Marta Tonello1 Ariela Hoxha1 Savino Sciascia2 Maria J. Cuadrado2 José O. Latino3 Sebastian Udry3 Tatiana Reshetnyak4 Nathalie Costedoat-Chalumeau5,6,7 Nathalie Morel5,6 Luca Marozio8 Angela Tincani9 Laura Andreoli9 Ewa Haladyj10 Pier L. Meroni11,12,13 Maria Gerosa11,12,13 Jaume Alijotas-Reig14,15 Sara Tenti16 Karoline Mayer-Pickel17 Michal J. Simchen18 Maria T. Bertero19 Sara De Carolis20 Véronique Ramoni21 Arsène Mekinian22 Elvira Grandone23 Aldo Maina24 Fátima Serrano25 Vittorio Pengo1,26 Munther A. Khamashta2,27,28 1Rheumatology Unit,

Read More